Brendan D. Looyenga

STAT3 Is Activated by JAK2 Independent of Key Oncogenic Driver Mutations in Non-Small Cell Lung Carcinoma

Brendan D. Looyenga, Danielle Hutchings, Irene Cherni et al. · PLoS ONE · 2012 · 123 citations · Full text

Medicine, Cancer Biology, Oncology +13

Chromosomal amplification of leucine-rich repeat kinase-2 (LRRK2) is required for oncogenic MET signaling in papillary renal and thyroid carcinomas

Brendan D. Looyenga, Kyle A. Furge, Karl Dykema et al. · Proceedings of the National Academy of Sciences · 2011 · 95 citations

Medicine, Cancer Biology, Oncology +17

A Mitochondrial RNAi Screen Defines Cellular Bioenergetic Determinants and Identifies an Adenylate Kinase as a Key Regulator of ATP Levels

Nathan Lanning, Brendan D. Looyenga, Audra L. Kauffman et al. · Cell Reports · 2014 · 94 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

Quercetin inhibits glucose transport by binding to an exofacial site on GLUT1

Kathryn E. Hamilton, Janelle Rekman, Leesha K. Gunnink et al. · Biochimie · 2018 · 80 citations · Full text

Life Sciences, Biochemistry, Pharmacology +7

Activin Induces x-Zone Apoptosis That Inhibits Luteinizing Hormone-Dependent Adrenocortical Tumor Formation in Inhibin-Deficient Mice

Felix Beuschlein, Brendan D. Looyenga, Stephanie E. Bleasdale et al. · Molecular and Cellular Biology · 2003 · 77 citations

Medicine, Endocrinology, Oncology +17